0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intramuscular Drug Delivery Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22C985
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intramuscular Drug Delivery Market Insights and Forecast to 2028
BUY CHAPTERS

Global Intramuscular Drug Delivery Market Research Report 2025

Code: QYRE-Auto-22C985
Report
September 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intramuscular Drug Delivery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Intramuscular Drug Delivery Market

Intramuscular Drug Delivery Market

The global market for Intramuscular Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery.
The Intramuscular Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intramuscular Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intramuscular Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intramuscular Drug Delivery Market Report

Report Metric Details
Report Name Intramuscular Drug Delivery Market
CAGR 5%
Segment by Type
  • Drug Molecule
  • Delivery Devices
Segment by Application
  • Infectious Disease
  • Oncology
  • Autoimmune Diseases
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals, Pfizer, Pharmajet, Teva Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Intramuscular Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intramuscular Drug Delivery Market report?

Ans: The main players in the Intramuscular Drug Delivery Market are Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals, Pfizer, Pharmajet, Teva Pharmaceutical

What are the Application segmentation covered in the Intramuscular Drug Delivery Market report?

Ans: The Applications covered in the Intramuscular Drug Delivery Market report are Infectious Disease, Oncology, Autoimmune Diseases

What are the Type segmentation covered in the Intramuscular Drug Delivery Market report?

Ans: The Types covered in the Intramuscular Drug Delivery Market report are Drug Molecule, Delivery Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Molecule
1.2.3 Delivery Devices
1.3 Market by Application
1.3.1 Global Intramuscular Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intramuscular Drug Delivery Market Perspective (2020-2031)
2.2 Global Intramuscular Drug Delivery Growth Trends by Region
2.2.1 Global Intramuscular Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2020-2025)
2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2026-2031)
2.3 Intramuscular Drug Delivery Market Dynamics
2.3.1 Intramuscular Drug Delivery Industry Trends
2.3.2 Intramuscular Drug Delivery Market Drivers
2.3.3 Intramuscular Drug Delivery Market Challenges
2.3.4 Intramuscular Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intramuscular Drug Delivery Players by Revenue
3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2020-2025)
3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Intramuscular Drug Delivery Revenue
3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2024
3.5 Global Key Players of Intramuscular Drug Delivery Head office and Area Served
3.6 Global Key Players of Intramuscular Drug Delivery, Product and Application
3.7 Global Key Players of Intramuscular Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intramuscular Drug Delivery Breakdown Data by Type
4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2020-2025)
4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2026-2031)
5 Intramuscular Drug Delivery Breakdown Data by Application
5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2020-2025)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Intramuscular Drug Delivery Market Size (2020-2031)
6.2 North America Intramuscular Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Intramuscular Drug Delivery Market Size by Country (2020-2025)
6.4 North America Intramuscular Drug Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intramuscular Drug Delivery Market Size (2020-2031)
7.2 Europe Intramuscular Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Intramuscular Drug Delivery Market Size by Country (2020-2025)
7.4 Europe Intramuscular Drug Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2020-2031)
8.2 Asia-Pacific Intramuscular Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intramuscular Drug Delivery Market Size (2020-2031)
9.2 Latin America Intramuscular Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2020-2025)
9.4 Latin America Intramuscular Drug Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2020-2031)
10.2 Middle East & Africa Intramuscular Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Details
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.1.5 Antares Pharma Recent Development
11.2 Eli Lily
11.2.1 Eli Lily Company Details
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Intramuscular Drug Delivery Introduction
11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.2.5 Eli Lily Recent Development
11.3 Galaxo
11.3.1 Galaxo Company Details
11.3.2 Galaxo Business Overview
11.3.3 Galaxo Intramuscular Drug Delivery Introduction
11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.3.5 Galaxo Recent Development
11.4 HMD pharmaceuticals
11.4.1 HMD pharmaceuticals Company Details
11.4.2 HMD pharmaceuticals Business Overview
11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.4.5 HMD pharmaceuticals Recent Development
11.5 Inovio Pharmaceuticals
11.5.1 Inovio Pharmaceuticals Company Details
11.5.2 Inovio Pharmaceuticals Business Overview
11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.5.5 Inovio Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Intramuscular Drug Delivery Introduction
11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Intramuscular Drug Delivery Introduction
11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 Pacira Pharmaceuticals
11.8.1 Pacira Pharmaceuticals Company Details
11.8.2 Pacira Pharmaceuticals Business Overview
11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.8.5 Pacira Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Intramuscular Drug Delivery Introduction
11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Pharmajet
11.10.1 Pharmajet Company Details
11.10.2 Pharmajet Business Overview
11.10.3 Pharmajet Intramuscular Drug Delivery Introduction
11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.10.5 Pharmajet Recent Development
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Details
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2020-2025)
11.11.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug Molecule
 Table 3. Key Players of Delivery Devices
 Table 4. Global Intramuscular Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Intramuscular Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Intramuscular Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Intramuscular Drug Delivery Market Share by Region (2020-2025)
 Table 8. Global Intramuscular Drug Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Intramuscular Drug Delivery Market Share by Region (2026-2031)
 Table 10. Intramuscular Drug Delivery Market Trends
 Table 11. Intramuscular Drug Delivery Market Drivers
 Table 12. Intramuscular Drug Delivery Market Challenges
 Table 13. Intramuscular Drug Delivery Market Restraints
 Table 14. Global Intramuscular Drug Delivery Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Intramuscular Drug Delivery Market Share by Players (2020-2025)
 Table 16. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2024)
 Table 17. Ranking of Global Top Intramuscular Drug Delivery Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Intramuscular Drug Delivery Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Intramuscular Drug Delivery, Headquarters and Area Served
 Table 20. Global Key Players of Intramuscular Drug Delivery, Product and Application
 Table 21. Global Key Players of Intramuscular Drug Delivery, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Intramuscular Drug Delivery Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Intramuscular Drug Delivery Revenue Market Share by Type (2020-2025)
 Table 25. Global Intramuscular Drug Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Intramuscular Drug Delivery Revenue Market Share by Type (2026-2031)
 Table 27. Global Intramuscular Drug Delivery Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Intramuscular Drug Delivery Revenue Market Share by Application (2020-2025)
 Table 29. Global Intramuscular Drug Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Intramuscular Drug Delivery Revenue Market Share by Application (2026-2031)
 Table 31. North America Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Intramuscular Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Intramuscular Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Intramuscular Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Intramuscular Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Intramuscular Drug Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Intramuscular Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Intramuscular Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Antares Pharma Company Details
 Table 47. Antares Pharma Business Overview
 Table 48. Antares Pharma Intramuscular Drug Delivery Product
 Table 49. Antares Pharma Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 50. Antares Pharma Recent Development
 Table 51. Eli Lily Company Details
 Table 52. Eli Lily Business Overview
 Table 53. Eli Lily Intramuscular Drug Delivery Product
 Table 54. Eli Lily Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 55. Eli Lily Recent Development
 Table 56. Galaxo Company Details
 Table 57. Galaxo Business Overview
 Table 58. Galaxo Intramuscular Drug Delivery Product
 Table 59. Galaxo Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 60. Galaxo Recent Development
 Table 61. HMD pharmaceuticals Company Details
 Table 62. HMD pharmaceuticals Business Overview
 Table 63. HMD pharmaceuticals Intramuscular Drug Delivery Product
 Table 64. HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 65. HMD pharmaceuticals Recent Development
 Table 66. Inovio Pharmaceuticals Company Details
 Table 67. Inovio Pharmaceuticals Business Overview
 Table 68. Inovio Pharmaceuticals Intramuscular Drug Delivery Product
 Table 69. Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 70. Inovio Pharmaceuticals Recent Development
 Table 71. Merck Company Details
 Table 72. Merck Business Overview
 Table 73. Merck Intramuscular Drug Delivery Product
 Table 74. Merck Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 75. Merck Recent Development
 Table 76. Novartis Company Details
 Table 77. Novartis Business Overview
 Table 78. Novartis Intramuscular Drug Delivery Product
 Table 79. Novartis Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 80. Novartis Recent Development
 Table 81. Pacira Pharmaceuticals Company Details
 Table 82. Pacira Pharmaceuticals Business Overview
 Table 83. Pacira Pharmaceuticals Intramuscular Drug Delivery Product
 Table 84. Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 85. Pacira Pharmaceuticals Recent Development
 Table 86. Pfizer Company Details
 Table 87. Pfizer Business Overview
 Table 88. Pfizer Intramuscular Drug Delivery Product
 Table 89. Pfizer Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 90. Pfizer Recent Development
 Table 91. Pharmajet Company Details
 Table 92. Pharmajet Business Overview
 Table 93. Pharmajet Intramuscular Drug Delivery Product
 Table 94. Pharmajet Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 95. Pharmajet Recent Development
 Table 96. Teva Pharmaceutical Company Details
 Table 97. Teva Pharmaceutical Business Overview
 Table 98. Teva Pharmaceutical Intramuscular Drug Delivery Product
 Table 99. Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2020-2025) & (US$ Million)
 Table 100. Teva Pharmaceutical Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Intramuscular Drug Delivery Picture
 Figure 2. Global Intramuscular Drug Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intramuscular Drug Delivery Market Share by Type: 2024 VS 2031
 Figure 4. Drug Molecule Features
 Figure 5. Delivery Devices Features
 Figure 6. Global Intramuscular Drug Delivery Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Intramuscular Drug Delivery Market Share by Application: 2024 VS 2031
 Figure 8. Infectious Disease Case Studies
 Figure 9. Oncology Case Studies
 Figure 10. Autoimmune Diseases Case Studies
 Figure 11. Intramuscular Drug Delivery Report Years Considered
 Figure 12. Global Intramuscular Drug Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Intramuscular Drug Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Intramuscular Drug Delivery Market Share by Region: 2024 VS 2031
 Figure 15. Global Intramuscular Drug Delivery Market Share by Players in 2024
 Figure 16. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2024
 Figure 18. North America Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Intramuscular Drug Delivery Market Share by Country (2020-2031)
 Figure 20. United States Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Intramuscular Drug Delivery Market Share by Country (2020-2031)
 Figure 24. Germany Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Intramuscular Drug Delivery Market Share by Region (2020-2031)
 Figure 32. China Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Intramuscular Drug Delivery Market Share by Country (2020-2031)
 Figure 40. Mexico Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Intramuscular Drug Delivery Market Share by Country (2020-2031)
 Figure 44. Turkey Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Intramuscular Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 48. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 49. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 50. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 51. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 52. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 53. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 54. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 56. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 57. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS